<i>In Vitro</i> and <i>In Vivo</i> Antibacterial Activities of a Novel Quinolone Compound, OPS-2071, against Clostridioides difficileDaisuke Oka, Makoto Matsumoto, Xue Jingbo et al.|Antimicrobial Agents and Chemotherapy|2021Cited by 9
Antibacterial and Immunosuppressive Effects of OPS-2071, a Candidate Therapy for Inflammatory Bowel DiseaseMasayoshi Satō, Katsuya Inagaki, Kazuyuki Fujii et al.|Digestive Diseases and Sciences|2021Cited by 4
<i>In vitro</i> antibacterial activity of OPS-2071 against Gram-positive and Gram-negative enteropathogenic bacteriaDaisuke Oka, Makoto Matsumoto, Yasuhiko Suzuki et al.|Journal of Antimicrobial Chemotherapy|2022Cited by 3